Focal Therapy for Prostate Cancer: Complications and Their Treatment
Open Access
- 12 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8, 696242
- https://doi.org/10.3389/fsurg.2021.696242
Abstract
Focal therapy is a modern alternative to selectively treat a specific part of the prostate harboring clinically significant disease while preserving the rest of the gland. The aim of this therapeutic approach is to retain the oncological benefit of active treatment and to minimize the side-effects of common radical treatments. The oncological effectiveness of focal therapy is yet to be proven in long-term robust trials. In contrast, the toxicity profile is well-established in randomized controlled trials and multiple robust prospective cohort studies. This narrative review summarizes the relevant evidence on complications and their management after focal therapy. When compared to whole gland treatments, focal therapy provides a substantial benefit in terms of adverse events reduction and preservation of genito-urinary function. The most common complications occur in the peri-operative period. Urinary tract infection and acute urinary retention can occur in up to 17% of patients, while dysuria and haematuria are more common. Urinary incontinence following focal therapy is very rare (0–5%), and the vast majority of patients recover in few weeks. Erectile dysfunction can occur after focal therapy in 0–46%: the baseline function and the ablation template are the most important factors predicting post-operative erectile dysfunction. Focal therapy in the salvage setting after external beam radiotherapy has a significantly higher rate of complications. Up to one man in 10 will present a severe complication.This publication has 35 references indexed in Scilit:
- Radical prostatectomy versus brachytherapy for clinically localized prostate cancer on oncological and functional outcomes: a meta-analysisTranslational Andrology and Urology, 2020
- Epidemiology of Prostate CancerWorld Journal of Oncology, 2019
- MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisThe New England Journal of Medicine, 2018
- Focal therapy as primary treatment for localized prostate cancer: definition, needs and futureFuture Oncology, 2017
- The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsyBritish Journal of Cancer, 2017
- Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus ProjectProstate Cancer and Prostatic Diseases, 2017
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyThe Lancet, 2017
- Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus MeetingEuropean Urology, 2014
- Imaging modalities in focal therapyCurrent Opinion in Urology, 2014
- Long-Term Functional Outcomes after Treatment for Localized Prostate CancerThe New England Journal of Medicine, 2013